Long-term efficacy of pregabalin in generalized anxiety disorder. (Record no. 17603153)

MARC details
000 -LEADER
fixed length control field 01530 a2200445 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515100721.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200802s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0268-1315
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1097/YIC.0b013e3282f0f0d7
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Feltner, Douglas
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20080214
245 00 - TITLE STATEMENT
Title Long-term efficacy of pregabalin in generalized anxiety disorder.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. International clinical psychopharmacology
Date of publication, distribution, etc. Jan 2008
300 ## - PHYSICAL DESCRIPTION
Extent 18-28 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adolescent
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anti-Anxiety Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anxiety Disorders
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Double-Blind Method
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pregabalin
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Psychiatric Status Rating Scales
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sample Size
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Secondary Prevention
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element gamma-Aminobutyric Acid
General subdivision adverse effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wittchen, Hans-Ulrich
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kavoussi, Richard
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Brock, Jerri
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Baldinetti, Francesca
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pande, Atul C
773 0# - HOST ITEM ENTRY
Title International clinical psychopharmacology
Related parts vol. 23
-- no. 1
-- p. 18-28
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1097/YIC.0b013e3282f0f0d7">https://doi.org/10.1097/YIC.0b013e3282f0f0d7</a>
Public note Available from publisher's website

No items available.